Active Pharmaceutical Ingredients Market Research Report
PREBOOK THIS REPORT - SAVE 10%

Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026

TO BE PUBLISHED : Nov 2021 | Pages : 279

Up to $525 off Prebook this report

THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET SIZE IS EXPECTED TO REACH USD 266.80 BILLION BY 2026, GROWING AT A CAGR OF 6.22% DURING THE PERIOD 2021-2026

Active Pharmaceutical Ingredients (API) Market Size, Share, & Trends Analysis Report By Application (Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others), Molecule Type (Small and Large), Type of manufacturers (Captive and Merchant), Type of drugs (Prescription and Over the counter), Synthesis Type (Synthetic and Biotech), and Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026.

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

279 Pages

133 Tables

88 Charts

5 Regions

18 Countries

25 Companies

6 Market Segment

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 266.80 BILLION (2026)
CAGR 6.22% (2021-2026)
BASE YEAR 2020
FORECAST YEAR 2021-2026
MARKET SEGMENTS Application (Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others), Molecule Type (Small and Large), Type of manufacturers (Captive and Merchant), Type of drugs (Prescription and Over the counter), and Synthesis Type (Synthetic and Biotech)
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED US, Canada, United Kingdom, Germany, France, Italy, Spain, Russia, China, India, Indonesia, Japan, Singapore, Brazil, Mexico, Saudi Arabia, South Africa, and UAE

ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET OUTLOOK

The global active pharmaceutical ingredients (API) market size was valued at USD 185.72 billion in 2020 and is expected to reach USD 266.80 billion by 2026, growing at a compound annual growth rate (CAGR) of 6.22%. 

Digitalization, big data, and artificial intelligence are accelerating the transformation of the pharmaceutical industry. The growing trend toward new high-tech therapeutics, with the emergence of novel and innovative delivery system and the evolution of personalized medicines, will further emphasize the growing demand for advanced Aher. Innovative and Biotech APIs are fueling the demand for APIs across the globe. The global active pharmaceutical ingredient (API) market is set to have significant growth in the forecasted period. The growth of the market can be amplified by the growing geriatric and aging population globally. Manufacturers are significantly investing in Research and development and must continue spending on research and development initiatives. As the industry is getting fragmented and profit margins are thin, there is a need for constant innovation.

SNIPPETS

  • Based on Molecule type, the small molecule is the largest segment and is projected to grow higher than the overall API market.
  • Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth in the market.
  • The oncology API market size is the largest in the application segment. The expected growth is because of large-scale development resulting from the availability of abundant prospects available in the global forecast period of 2020-2026.

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION 

This research report includes a detailed segmentation by

  • Application 
  • Molecule Type
  • Type of manufacturers
  • Type of drugs
  • Synthesis Type  

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTS

  • The increasing awareness of various APIs' improved efficacy on targeted cancerous cells is also propelling their demand for oncology drugs. Oncology API will register a handsome growth until 2026.
  • The rise in internet penetration enables various online platforms to collaborate with pharmaceutical companies to deliver drugs such as analgesics at the doorstep of consumers. 
  • The captive segment held the largest market share due to major key companies' intensive capitalization in developing high-end manufacturing facilities.
  • Companies in the biotech API manufacturing services market are acquiring agency perspectives from the Center for drug evaluation and research (CDER) to gain a competitive edge over other players. 

GEOGRAPHICAL ANALYSIS

The North American region is highly fragmented, and many global and regional players are present in the active pharmaceutical ingredient industry. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. The North American API industry is anticipated to show increasing growth in the forecasted period. 

The European market grew with the increase in technological advancements to enhance the capabilities and boost the manufacturing skills of the players. The active pharmaceutical ingredients market in Europe is expected to reach almost USD 50 billion in the coming years.

VENDORS ANALYSIS

The global API market is highly concentrated and competitive. Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals are prominent vendors in the industry. Over the past decade, several companies have engaged in mergers and acquisitions to establish their presence in the industry. Mergers and acquisitions offer several benefits, such as better access to procuring raw materials, distribution, and R&D, and are largely driven by consolidation. Manufacturers must always keep pace with the latest industry regulations for manufacturing APIs to avoid penalties and criminal sanctions. The demand for APIs is expected to accelerate due to the increase in the geriatric population and the increase in awareness for better healthcare.

The active pharmaceutical ingredients market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

  • Application
    • Oncology
    • Cardiovascular Disease
    • Anti-infectives
    • Central Nervous System
    • Respiratory diseases
    • Diabetes
    • Pain management
    • Others
  • Molecule Type
    • Small
    • Large
  • Type of manufacturers
    • Captive
    • Merchant
  • Type of drugs
    • Prescription
    • Over the counter
  • Synthesis Type
    • Synthetic
    • Biotech
  • Geography
  • North America
    • US
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • India
    • Indonesia
    • Japan
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Frequently Asked Questions

The active pharmaceutical ingredients (API) market is expected to reach USD 266.80 billion by 2026.
Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others are the different applications in the global active pharmaceutical ingredient market.
Pfizer Inc., Cipla Inc., Novartis AG, Mylan N.V., and Sun Pharmaceuticals Industries Ltd. are the key players in the active pharmaceutical ingredient (API) market.
Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth.
The invention of new generation API and increase in demand for generic drugs.
Download Free Sample
Read More

Select a license type that suits your business needs

Single User Licence
$3375.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$3825.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$4725.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1350.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Clients

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date